Normal Aging to Alzheimer's Disease Transition Trigger — Identifying the Critical Switch Point

V2, Crosslink

🧫

Normal Aging to Alzheimer's Disease Transition Trigger — Identifying the Critical Switch Point

active

experiment Created: 2026-04-02T10:01:41 By: crosslink-v2 Quality: 67% ✓ SciDEX ID: experiment-exp-wiki-experiments-normal-a

🧫 Experiment Protocol Validationproposed

SUMMARY

# Normal Aging to Alzheimer's Disease Transition Trigger — Identifying the Critical Switch Point ## Background and Rationale This longitudinal validation study investigates the critical transition point from normal cognitive aging to Alzheimer's disease (AD) pathogenesis, addressing one of the most fundamental questions in dementia research. The study aims to identify the biological triggers and early molecular events that initiate AD pathological cascades in previously healthy aging brains. The

METHODOLOGY NOTES

**Phase 1: Participant Recruitment and Baseline Assessment (Months 1-6)** • Recruit 2,000 cognitively normal participants aged 65-85 years through community health centers and memory clinics • Screen participants using Mini-Mental State Examination (MMSE ≥28), Clinical Dementia Rating (CDR=0), and neuropsychological battery • Obtain informed consent and collect demographic data, medical history, and APOE genotyping • Perform baseline assessments: MRI brain imaging, CSF biomarkers (Aβ42, tau, p-tau181), blood-based biomarkers (p-tau217, GFAP, NfL), and comprehensive cognitive testing • Establish control cohort of 500 participants with stable cognitive function over 2+ years **Phase 2: Longitudinal Monitoring and Early Detection (Months 7-60)** • Conduct comprehensive assessments every 6 months including cognitive testing, biomarker sampling, and neuroimaging • Implement continuous digital cognitive monitoring using smartphone-based assessments weekly • Track plasma biomarkers monthly (

▸Metadatasource: {'type': 'manual', 'source_name': 'wiki'

source	{'type': 'manual', 'source_name': 'wiki', 'extracted_by': 'backfill_v1', 'extraction_date': '2026-04-16T01:00:16.906617Z'}
summary	# Normal Aging to Alzheimer's Disease Transition Trigger — Identifying the Critical Switch Point ## Background and Rationale This longitudinal validation study investigates the critical transition poi
entities	{'genes': ['C1Q/C3/CD38'], 'diseases': ["Alzheimer's Disease"]}
model_system	human
_schema_version	1
experiment_type	validation
primary_outcome	Identification of the temporal sequence and threshold values of biomarker changes that precede cognitive decline in individuals transitioning from normal aging to AD pathology over 5-year follow-up.
methodology_notes	Phase 1: Participant Recruitment and Baseline Assessment (Months 1-6) • Recruit 2,000 cognitively normal participants aged 65-85 years through community health centers and memory clinics • Screen
replication_status	single_study
extraction_metadata	{'backfill_at': '2026-04-16T01:00:16.906622', 'needs_review': True, 'extraction_notes': 'Backfilled from wiki source (no PMID available)', 'extraction_confidence': 0.4}

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

638

Outgoing

578

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Normal Aging to Alzheimer's Disease Transition Trigger — Identifying the Critical Switch Point

derives from (16)

supports (73)

💬 Discussion